##common.pageHeaderLogo.altText##

Viewpoint

Vol. 155 No. 10 (2025)

Vaccination at a crossroad: science, politics and public trust

Cite this as:
Swiss Med Wkly. 2025;155:5072
Published
29.10.2025

Summary

Vaccine hesitancy threatens to erode one of medicine’s greatest achievements. Recent measles outbreaks in Europe and the United States illustrate the consequences of declining confidence. At the centre lies misinformation, amplified through digital networks, from the discredited vaccine–autism claim to the misconception that COVID-19 mRNA vaccines were rushed. Such narratives echo longstanding resistance to vaccination, magnified by political polarisation and compounded by inequities in access. Yet pathogens continue to evolve, requiring sustained innovation in immunology, genomic surveillance, artificial intelligence and mRNA platforms. Science alone, however, cannot overcome mistrust. Transparent communication, broad engagement by healthcare teams and equitable distribution are indispensable. Protecting trust is essential if vaccines are to prevent disease, reduce mortality and prepare society for future infectious threats.

References

  1. 1. Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol. 2021 Feb;21(2):83–100. doi: https://doi.org/10.1038/s41577-020-00479-7
  2. 2. Berkley S. Unraveling the arc of vaccine progress. Science. 2025 Aug;389(6763):eaea7053. 10.1126/science.aea7053
  3. 3. European Centre for Disease Prevention and Control. Measles. In : ECDC. Annual Epidemiological Report for 2024. Stochholm :ECED; 2025.
  4. 4. Soneman EK. Measles. JAMA. Published online August 14, 2025.
  5. 5. Larson HJ, Gakidou E, Murray CJ. The vaccine-hesitant moment. N Engl J Med. 2022 Jul;387(1):58–65. doi: https://doi.org/10.1056/NEJMra2106441
  6. 6. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998 Feb;351(9103):637–41. doi: https://doi.org/10.1016/S0140-6736(97)11096-0
  7. 7. The Editors of The Lancet. Retraction—ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 2010 Feb;375(9713):445. doi: https://doi.org/10.1016/S0140-6736(10)60175-4
  8. 8. Catli NE, Özyurt G. The relationship between autism spectrum disorders and vaccination : review of the current literature. Trends Pediatr. 2025;6(2):76–81. doi: https://doi.org/10.59213/TP.2025.222
  9. 9. Andersson NW, Bech Svalgaard I, Hoffmann SS, Hviid A. Aluminium-adsorbed vaccines and chronic diseases in childhood. A nationwide cohort study. Ann Intern Med. 2025 Jul;•••: 10.7326/ANNALS-25-00997
  10. 10. Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018 Apr;17(4):261–79. doi: https://doi.org/10.1038/nrd.2017.243
  11. 11. Weissman D, Ni H, Scales D, Dude A, Capodici J, McGibney K, et al. HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response. J Immunol. 2000 Oct;165(8):4710–7. doi: https://doi.org/10.4049/jimmunol.165.8.4710
  12. 12. Karikó K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005 Aug;23(2):165–75. doi: https://doi.org/10.1016/j.immuni.2005.06.008
  13. 13. Cullis PR, Felgner PL. The 60-year evolution of lipid nanoparticles for nucleic acid delivery. Nat Rev Drug Discov. 2024 Sep;23(9):709–22. doi: https://doi.org/10.1038/s41573-024-00977-6
  14. 14. Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022 Sep;22(9):1293–302. doi: https://doi.org/10.1016/S1473-3099(22)00320-6
  15. 15. Soyfer VN. The consequences of political dictatorship for Russian science. Nat Rev Genet. 2001 Sep;2(9):723–9. doi: https://doi.org/10.1038/35088598
  16. 16. Hao X. Science in China: 30 years on. Cell. 2008 Aug;134(3):375–7. doi: https://doi.org/10.1016/j.cell.2008.07.035
  17. 17. White RM. Unravelling the Tuskegee study of untreated syphilis. Arch Intern Med. 2000 Mar;160(5):585–98. doi: https://doi.org/10.1001/archinte.160.5.585
  18. 18. Krumholz HM, Ross JS, Presler AH, Egilman DS. What have we learnt from Vioxx? BMJ. 2007 Jan;334(7585):120–3. doi: https://doi.org/10.1136/bmj.39024.487720.68
  19. 19. Altice FL. The viral playbook threatening the National Institutes of Health: a call to inoculate the immune system of American science. Lancet Reg Health Am. 2025 Jun;47:101145. 10.1016/j.lana.2025.101145
  20. 20. Fauci AS. It ain’t over till it’s over…but it’s never over – Emerging and reemerging infectious diseases. N Engl J Med. 2022 Dec;387(22):2009–11. doi: https://doi.org/10.1056/NEJMp2213814
  21. 21. Ebert D. The Red Queen and the timescale of antagonistic coevolution : parasite selection for genetic diversity. Ann. Rev Genet. 2025 ;59 :10.1-10.22. doi: https://doi.org/10.1146/annurev-genet-112024-091229
  22. 22. Murphy KM, Weaver C, Berg LJ. Failure of host defense mechanisms. In: Murphy KM, Weaver C, Berg LJ, editors. Janeway’s Immunobiology. 10th ed. New York: W. W. Norton & Company; 2022. pp. 534–662.
  23. 23. Jumper J, Hassabis D. The protein structure revolution and its implication for medicine. 2023 Albert Lasker Basic Medical Research Award. JAMA. 2023 Oct;330(15):1425–6. doi: https://doi.org/10.1001/jama.2023.17095
  24. 24. Fang Z, Ran H, Zhang Y, Chen C, Lin P, Zhang X, et al. AlphaFold 3: an unprecedent opportunity for fundamental research and drug development. Precis Clin Med. 2025 Jul;8(3):pbaf015. 10.1093/pcmedi/pbaf015
  25. 25. Gasperini G, Baylor N, Black S, Bloom DE, Cramer J, de Lannoy G, et al. Vaccinology in the artificial intelligence era. Sci Transl Med. 2025 Apr;17(794):eadu3791. doi: https://doi.org/10.1126/scitranslmed.adu3791
  26. 26. Larson HJ, de Figueiredo A, Xiahong Z, Schulz WS, Verger P, Johnston IG, et al. The state of vaccine confidence 2016 : global insights through a 67-country survey. EBioMedicine. 2016 Oct;12:295–301. doi: https://doi.org/10.1016/j.ebiom.2016.08.042
  27. 27. https://europa.eu/eurobarometer/screen/home
  28. 28. Patrick-Smith M, Emary K, Hodgson SH, Thomas TM, te Water Naude R, Stuart ASV, et al. Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials : experience from the United Kingdom’s first COVID-19 vaccine trial. 2024 ;42 :126391 doi: https://doi.org/10.1016/j.vaccine.2024.126391